Publication | Closed Access

X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake

Iodinated AnaloguesRuthenium Anticancer DrugsEngineeringMedicineTheranosticsX-ray Fluorescence ImagingTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyMolecular ImagingDrug Discovery